<?xml version="1.0" encoding="UTF-8"?>
<fig id="ppat.1006748.g010" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.ppat.1006748.g010</object-id>
 <label>Fig 10</label>
 <caption>
  <title>CCR2
   <sup>+</sup> hematopoietic cells protect 
   <italic>Irf3</italic>
   <sup>
    <italic>-/-</italic>
   </sup>;
   <italic>Irf7</italic>
   <sup>-/-</sup> mice from severe RRV infection.
  </title>
  <p>
   <italic>Irf3</italic>
   <sup>
    <italic>-/-</italic>
   </sup>
   <italic>;Irf7</italic>
   <sup>-/-</sup> C57BL/6 mice (n = 5/group) were lethally irradiated and reconstituted with 
   <italic>Irf3</italic>
   <sup>
    <italic>-/-</italic>
   </sup>
   <italic>;Irf7</italic>
   <sup>-/-</sup> or CCR2-DTR bone marrow. At 6 weeks post-irradiation, mice were inoculated in the left rear footpad with 10 PFU of RRV-T48-nsP1
   <sup>6M</sup>. At days -1 and +2 relative to infection, mice were i.p. administered PBS or DT. Mice were monitored daily for (A) morbidity and (B) mortality. 
   <italic>P</italic> values were determined by two-way ANOVA with a Bonferroniâ€™s multiple comparisons test. ***, 
   <italic>P</italic> &lt; 0.001. At 7 dpi, (C) viral RNA levels in skeletal muscle tissue were quantified by qRT-PCR and 
   <italic>P</italic> values were determined by an unpaired t-test. ***, 
   <italic>P</italic> &lt; 0.001.
  </p>
 </caption>
 <graphic xlink:href="ppat.1006748.g010" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
